The well-being of the lymphoma community is the top priority of the Lymphoma Research Foundation (LRF). People with cancer, who are in active cancer treatment
Read More >
By Michael Werner and Christina Kazhe The COVID-19 pandemic has brought the country to a crawl. Lawmakers and consumers alike are rightly worried about the
Read More >
On November 2, 2019, the Lymphoma Research Foundation sent a letter to Donald Thompson, Director, Division of Acute Care at the Centers for Medicare and Medicaid Services requesting for MS-DRG reclassification for certain cases involving the use of chimeric antigen receptor T-cell (CAR T-cell) therapies.
Read More >
On July 10, the Lymphoma Research Foundation (LRF) is participating in a day of action in support of the Clinical Treatment Act, a bill that
Read More >Every year the National Institutes of Health (NIH) and National Cancer Institute (NCI) are required to prepare for the President and the Congress its best
Read More >
In the face of declining federal and institutional resources, the Lymphoma Research Foundation’s (LRF) commitment to supporting early career lymphoma researchers has become more critical
Read More >The Lymphoma Research Foundation (LRF) is proud to be a national thought leader in the area of public policy, advocating for polices and legislation that
Read More >
As part of the Lymphoma Research Foundation’s ongoing efforts in support of early career lymphoma researchers, the Foundation was proud to host a Biden Cancer
Read More >
Since 2011, the Lymphoma Research Foundation (LRF) has been a pioneer in shedding a “light” on lymphoma during September, recognized each year by the United
Read More >This month, the Lymphoma Research Foundation endorsed the bipartisan Cancer Care Planning and Communications (CCPC) Act. Co-Sponsored by U.S. Congressmen Mark DeSaulnier (D-CA) and Ted
Read More >
